-
EU continues to tighten noose on vitamin and mineral limits
12 June 2023
European regulator, EFSA, continues its assault on individual nutrient tolerable upper limits, ANH responds to its latest consultation on vitamin D to protect consumer freedom of choice
-
Sunshine vitamin covid protection that governments need to back
28 October 2020
ANH-Intl launches 'Test & Take: Vitamin D' campaign!
-
Vitamin D - what governments are and aren't telling us
22 October 2020
Watch the prequel video to our new TEST & TAKE: VITAMIN D campaign
-
ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?
23 January 2020
We take a look at where CBD regulation might be going and whether we should be concerned about safety
-
Call for concerted action on Vitamin C in C*v*d crisis
02 April 2020
Dr Damien Downing and Rob Verkerk set out urgent case for wider use of vitamin C
-
ANH Covid Zone
This is our Covid Zone campaign page that links you to all the content we've created and published on our website as it relates to Covid-19 since 12 March 2020.
-
ANH News Beat (week 34/2024)
21 August 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. This week vaping changes cell DNA; Should we fortify food with vitamin D?; Canadian Charter for Health Freedom; Upcoming interviews and events plus the latest covid news and more
-
ANH News Beat (week 31/2024)
01 August 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. This week vitamin D and oral health; Pesticide cancer risk same as smoking; Australia considers changing gene editing definitions; The latest from the ANH-USA team plus Covid updates
-
Vitamin B12, cancer and the rumour mill
04 September 2019
How two journal articles got misinterpreted and fuelled confusion over B12’s safety
-
EU prepares for ban on therapeutic doses of B6
15 February 2023
Halving the previous Tolerable Upper Level without any new risk data signals EU intention to limit freedom of choice and prevent the vitamin’s high dose use that includes reducing Alzheimer’s risk and symptoms of premenstrual syndrome